Literature DB >> 28775560

IMPROVED ACCURACY RATES OF FNAC INTERPRETATION IN BENIGN BREAST LESIONS.

G U Deshpande1, Sunita Suri2, Ramji Rai3.   

Abstract

We carried out a retrospective study of 194 biopsy proved benign breast lesions comparing the fine needle aspiration cytology (FNAC) diagnosis offered earlier. We reviewed the cytology smears based on recently advocated criteria and offered our fresh diagnosis. It was observed that we still overdiagnosed five cases of fibroadenomas and underdiagnosed four cases of fibrocystic change. However the quantum of such discrepancies decreased considerably than seen earlier. We could correctly diagnose two tubular adenomas and two intraductal papillomas. We also reduced the number of nonspecific diagnosis of benign breast disease from 24 to 08. Hence we could register an overall improvement of accuracy rate to 84.5% as compared to 58.8% achieved earlier.

Entities:  

Keywords:  Benign breast disease; Biopsy; FNAC

Year:  2017        PMID: 28775560      PMCID: PMC5531778          DOI: 10.1016/S0377-1237(17)30308-8

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  4 in total

1.  Fine-needle aspiration of the breast: diagnoses and pitfalls. A review of 3545 cases.

Authors:  T S Kline; L P Joshi; H S Neal
Journal:  Cancer       Date:  1979-10       Impact factor: 6.860

2.  Cytologic diagnosis of mammary tumors from aspiration biopsy smears. II. Studies on 210 fibroadenomas and 210 cases of benign dysplasia.

Authors:  J Linsk; G Kreuzer; J Zajicek
Journal:  Acta Cytol       Date:  1972 Mar-Apr       Impact factor: 2.319

3.  Subclassification of benign breast disease by fine needle aspiration cytology. Comparison of cytologic and histologic findings in 265 palpable breast masses.

Authors:  S J Maygarden; D B Novotny; D E Johnson; W J Frable
Journal:  Acta Cytol       Date:  1994 Mar-Apr       Impact factor: 2.319

4.  Cytologic criteria for fibroadenoma. A step-wise logistic regression analysis.

Authors:  K Bottles; J S Chan; E A Holly; S H Chiu; T R Miller
Journal:  Am J Clin Pathol       Date:  1988-06       Impact factor: 2.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.